Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 2
1980 1
1981 1
1982 1
1983 1
1984 1
1986 1
1987 2
1989 3
1990 3
1992 1
1993 2
1994 4
1995 6
1996 1
1997 9
1998 5
1999 6
2000 9
2001 4
2002 7
2003 2
2004 10
2005 7
2006 4
2007 7
2008 8
2009 15
2010 17
2011 14
2012 22
2013 18
2014 25
2015 15
2016 16
2017 19
2018 12
2019 21
2020 19
2021 20
2022 27
2023 12
2024 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

348 results

Results by year

Filters applied: . Clear all
Page 1
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication.
Miles D, Ciruelos E, Schneeweiss A, Puglisi F, Peretz-Yablonski T, Campone M, Bondarenko I, Nowecki Z, Errihani H, Paluch-Shimon S, Wardley A, Merot JL, Trask P, du Toit Y, Pena-Murillo C, Revelant V, Klingbiel D, Bachelot T; PERUSE investigators. Miles D, et al. Ann Oncol. 2021 Oct;32(10):1245-1255. doi: 10.1016/j.annonc.2021.06.024. Epub 2021 Jul 2. Ann Oncol. 2021. PMID: 34224826 Free article. Clinical Trial.
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial.
Del Mastro L, Poggio F, Blondeaux E, De Placido S, Giuliano M, Forestieri V, De Laurentiis M, Gravina A, Bisagni G, Rimanti A, Turletti A, Nisticò C, Vaccaro A, Cognetti F, Fabi A, Gasparro S, Garrone O, Alicicco MG, Urracci Y, Mansutti M, Poletti P, Correale P, Bighin C, Puglisi F, Montemurro F, Colantuoni G, Lambertini M, Boni L; Gruppo Italiano Mammella Investigators. Del Mastro L, et al. Lancet Oncol. 2022 Dec;23(12):1571-1582. doi: 10.1016/S1470-2045(22)00632-5. Epub 2022 Nov 10. Lancet Oncol. 2022. PMID: 36370716 Clinical Trial.
Microbiota and arthritis: cause or consequence?
Cafaro G, Cruciani G, Bruno L, Dal Pozzolo R, Colangelo A, Tromby F, Nicchi M, Pianese B, Perricone C, Gerli R, Bartoloni E. Cafaro G, et al. Among authors: cruciani g. Clin Exp Rheumatol. 2024 May;42(5):1097-1103. doi: 10.55563/clinexprheumatol/f6q4dc. Epub 2024 May 6. Clin Exp Rheumatol. 2024. PMID: 38743445 Free article. Review.
Vitamin E: Emerging aspects and new directions.
Galli F, Azzi A, Birringer M, Cook-Mills JM, Eggersdorfer M, Frank J, Cruciani G, Lorkowski S, Özer NK. Galli F, et al. Among authors: cruciani g. Free Radic Biol Med. 2017 Jan;102:16-36. doi: 10.1016/j.freeradbiomed.2016.09.017. Epub 2016 Nov 2. Free Radic Biol Med. 2017. PMID: 27816611 Review.
FragExplorer: GRID-Based Fragment Growing and Replacement.
Cross S, Cruciani G. Cross S, et al. Among authors: cruciani g. J Chem Inf Model. 2022 Mar 14;62(5):1224-1235. doi: 10.1021/acs.jcim.1c00821. Epub 2022 Feb 4. J Chem Inf Model. 2022. PMID: 35119269
Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy.
Boccanegra B, Cappellari O, Mantuano P, Trisciuzzi D, Mele A, Tulimiero L, De Bellis M, Cirmi S, Sanarica F, Cerchiara AG, Conte E, Meanti R, Rizzi L, Bresciani E, Denoyelle S, Fehrentz JA, Cruciani G, Nicolotti O, Liantonio A, Torsello A, De Luca A. Boccanegra B, et al. Among authors: cruciani g. Front Immunol. 2023 Apr 12;14:1119888. doi: 10.3389/fimmu.2023.1119888. eCollection 2023. Front Immunol. 2023. PMID: 37122711 Free PMC article.
Homodimeric enzymes as drug targets.
Cardinale D, Salo-Ahen OM, Ferrari S, Ponterini G, Cruciani G, Carosati E, Tochowicz AM, Mangani S, Wade RC, Costi MP. Cardinale D, et al. Among authors: cruciani g. Curr Med Chem. 2010;17(9):826-46. doi: 10.2174/092986710790712156. Curr Med Chem. 2010. PMID: 20156173 Review.
Indomethacin-based PROTACs as pan-coronavirus antiviral agents.
Desantis J, Mercorelli B, Celegato M, Croci F, Bazzacco A, Baroni M, Siragusa L, Cruciani G, Loregian A, Goracci L. Desantis J, et al. Among authors: cruciani g. Eur J Med Chem. 2021 Dec 15;226:113814. doi: 10.1016/j.ejmech.2021.113814. Epub 2021 Sep 4. Eur J Med Chem. 2021. PMID: 34534839 Free PMC article.
348 results